Paydirt
ASPE
Ticker

Aspen Neuroscience, Inc.

ASPE · Healthcare · Aspen Neuroscience, Inc. develops autologous induced pluripotent stem cell (iPSC)-derived cell replacement therapies for neurodegenerative…

Aspen Neuroscience, Inc. (ASPE), in the Healthcare sector, has 4 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 4 purchases and 0 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Nov 2 and filed Nov 4. The most active filer was ARCH Venture Fund X, L.P. with 1 filing. Data as of Nov 7 2026.

Add to watchlist
Filings, ttm
4
4 buys · 0 sells
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$68.0M
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Nov 2
Filed Nov 4
ADViAverage daily dollar volume
$17.2M
market data
Share price · 12M
$12.44 (-16.5%)
$14.89$13.33$11.76Oct 30Nov 4Nov 6

Adjusted for splits and dividends.

Volume by month
$68.0M$34.0M$0Dec 2024Jun 2025Dec 2025Jun 2026Nov 2026 · buys $68.0M
Buys $68.0M Sells $0

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months
AP ARCH Venture Fund X, L.P. 10% owner 1 filing · 1 buy, 0 sales AP ARCH Venture Partners XIV, L.P. 10% owner 1 filing · 1 buy, 0 sales OL Orbimed Advisors Llc Director 1 filing · 1 buy, 0 sales PT Peter A. Thompson Director 1 filing · 1 buy, 0 sales
Recent filings
Peter A. ThompsonPURCHASE Director $15.0M
1,000,000 sh × $15.00
Exec Nov 2
Filed Nov 4 · 6:47 PM ET Orbimed Advisors LlcPURCHASE Director $15.0M
1,000,000 sh × $15.00
Exec Nov 2
Filed Nov 4 · 6:43 PM ET ARCH Venture Fund X, L.P.PURCHASE 10% owner $20.0M
1,333,333 sh across 3 lots
Exec Nov 2
Filed Nov 2 · 9:50 PM ET ARCH Venture Partners XIV, L.P.PURCHASE 10% owner $18.0M
1,200,000 sh × $15.00
Exec Nov 2
Filed Nov 2 · 9:46 PM ET